APPLICATION OF RECENTLY PROPOSED EBMT/ ASTCT/ CIBMTR/APCMT CONSENSUS RISK STRATIFICATION FOR TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) IN CHILDREN

被引：0
|
作者：
Schoettler, Michelle [1 ,2 ]
Bryson, Elyse [1 ,2 ]
Spencer, Kathleen [1 ,2 ]
Qayed, Muna [1 ,2 ]
Chonat, Satheesh [1 ,2 ]
Westbrook, Adrianna [1 ,2 ,3 ]
Williams, Kirsten [1 ,2 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA
[3] Pediat Biostatist Core, Atlanta, GA USA
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O130
引用
收藏
页码：118 / 119
页数：2
相关论文
共 38 条
  • [21] Application of the Consensus Definition fi nition of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Requires a More Expansive Lens to Accurately Diagnose and Risk Stratify Patients-Beware - Beware Reliance on Schistocytes Alone
    Schoettler, Michelle L.
    Williams, Kirsten M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (08): : 818 - 820
  • [22] Recipient-Specific Antibodies (RSA) in Mismatched Related Transplants May Induce Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
    Sadowska-Klasa, Alicja
    Dukat-Mazurek, Anna
    Zielinska, Hanna
    Debska-Zielkowska, Joanna
    Moszkowska, Grazyna
    Piekarska, Agnieszka
    Gallamini, Andrea
    Zaucha, Jan Maciej
    BLOOD, 2022, 140 : 10486 - 10487
  • [23] TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) IN CHILDREN TREATED WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT): ONE CENTER STUDY
    Jarmolinski, Tomasz
    Rosa, Monika
    Bil-Lula, Iwona
    Korlaga, Joanna
    Kalwak, Krzysztof
    Ussowicz, Marek
    BONE MARROW TRANSPLANTATION, 2024, 59 : 612 - 612
  • [24] Unraveling the Challenges of Non-Responders to the Eculizumab Treatment with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
    Mizuno, Kana
    Teusink-Cross, Ashley
    Sabulski, Anthony
    Davies, Stella M.
    Jodele, Sonata
    TRANSPLANTATION AND CELLULAR THERAPY, 2025, 31 (02): : S542 - S543
  • [25] Risk factors for transplantation-associated thrombotic microangiopathy (TA-TMA): Analysis of twenty-five cases and matched controls.
    Daly, AS
    Hasegawa, WS
    Lipton, JH
    Messner, HA
    Kiss, TL
    BLOOD, 2001, 98 (11) : 193A - 193A
  • [26] TRANSPLANT ASSOCIATED-THROMBOTIC MICROANGIOPATHY (TA-TMA) AND POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES) IN A PATIENT WITH SICKLE CELL DISEASE POST BONE MARROW TRANSPLANT
    Sullivan, C. M.
    LeBlanc, Z.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 563 - 563
  • [27] Prospective Analysis of Complement Activation in Allogeneic Transplant Recipients and Correlation with Transplant Associated Thrombotic Microangiopathy (TA-TMA) and Acute Graft Versus Host Disease (aGVHD)
    Bostic, Matthew
    Zhao, Qiuhong
    Wall, Sarah A.
    Cataland, Spero R.
    Vasu, Sumithira
    BLOOD, 2018, 132
  • [28] Histologic Evidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) is Seen in Patients with Severe Gastrointestinal Graft Versus Host Disease (GI GVHD)
    Wall, Sarah
    Yearsley, Martha
    Blower, Luke
    Zhao, Qiuhong
    Agyeman, Akwasi
    Devine, Steven M.
    Cataland, Spero
    Vasu, Sumithira
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S204 - S205
  • [29] End Organ Damage Following Refractory/Recurrent Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Pediatric Patients Undergoing Autologous Hematopoietic Cell Transplantation
    Schoettler, Michelle Long
    Lehmann, Leslie E.
    Margossian, Steven
    Li, Anran
    Ma, Clement
    Duncan, Chrstine
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [30] Transplant-Associated Thrombotic Microangiopathy (TA-TMA) in a patient with acute GVHD after allogeneic hematopoietic stem cell transplantation successfully treated with eculizumab
    Donnini, I.
    Di Gioia, M.
    Nozzoli, C.
    Gozzini, A.
    Guidi, S.
    Saccardi, R.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S577 - S578
1234